Anecova is Swiss life science company offering Assisted Reproductive Technologies (ART)

Anecova is an innovative company based at EPFL Lausanne specialised in fertility treatment.

About Anecova

Anecova is a Swiss life science company focused on creating a more natural, physiological approach to Assisted Reproductive Technologies (ART). Our goals are to bring fertility treatment as close as possible to the circumstances of natural conception and to improve the overall quality of fertility care.

The company is ISO certified (9001 and 13485) and its AneVivo device is European Certified (CE MARK) and has also received the approval of several regulators in Europe, including the HFEA in the UK. Anecova was granted the Technology Pioneer Award in 2008 at the World Economic Forum. We stand strong on our values that are at the core of our organization and our daily activities:

Leadership – we make it happen
Innovation – we create and innovate
Team spirit – we grow and win together
Professionalism – we apply the highest standards
Entrepreneurship – we take initiative and create opportunities to make a better life

Anecova's Mission

To create and provide innovative assisted reproductive technologies (ART) and approaches that empowers patients to actively engage in their natural fertility treatment and improve outcomes.

Our Objectives

To create physiologic ART solutions

We strive to design, manufacture and make available physiologic solutions and procedures that are inherently closer to nature for patients requiring assisted reproduction.

To improve ART results and empower fertility patients

We will expand into areas of assisted reproduction patient care where our expertise can improve results and empower patients.

To continuously learn, innovate and thrive

We embrace continuous learning of expertise and knowledge through our own efforts and those of leading medical talents worldwide (gynaecologists, embryologists, psychologists and researchers) to advance ART.

To offer the highest standards

We provide the highest standards in excellence, quality, reliability, integrity, customer service and partnership to all interested parties.

To make our solutions widely available

We will make our solutions as widely available as possible, worldwide including in developing and emerging countries.

To develop a great organization

We are developing an organization that attracts, develops and retains outstanding individuals who share our mission, objectives and values.

Our Team

Anecova’s Board of Directors bring outstanding experiences and track records in ART (Assisted Reproductive Technologies), Medical Devices and Biotechnology. Together with a professional and passionate team we will create innovative fertility treatments that are as close as possible to the natural conception environment.

Management

Martin Velasco Founder, Chairman of the Board and CEO
Peter Svalander Chief Scientific Officer
Alison Velasco Business Development and Marketing Manager
Mathieu Astranskas Clinical and Training Manager
Julia Sutter Admin and Human Resource Manager
Sorina Plass Quality Assurance and Regulatory Manager

Board of Directors

Martin Velasco Founder, Chairman of the Board and CEO
Professor Nick Macklon MB ChB, MD, FRCO, Professor of Obstetrics and Gynaecology, Medical Director of the London's Women's Clinic
Professor Simon Fishel BSc (Class 1 Hons) PhD (Cantab) FRSB, Founder and President and Head of R&D CARE Fertility Group